<qa>  What is the name of the STUDY EVALUATING THE SAFETY AND PA PHASE 1 STUDY EVALUATING THE SAFETY AND PHARMACOKINETICS OF ABT-199 IN SUBJECTS WITH RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA AND NON-HODGKIN LYMPHOMA: 